VBI Vaccines Inc.

VBI Vaccines Inc. is a leading biopharmaceutical company dedicated to driving innovation in immunology for the prevention and treatment of diseases. Through its pioneering approach to virus-like particles (VLPs), including its proprietary enveloped VLP (eVLP) platform technology, VBI Vaccines Inc. develops advanced vaccine candidates. These vaccines are meticulously designed to mimic the natural presentation of viruses, harnessing the innate power of the human immune system.

Headquartered in Cambridge, Massachusetts, at 160 Second Street, Floor 3, Cambridge, MA 02142, US, VBI Vaccines Inc. is strategically positioned to target and overcome significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (CMV), as well as aggressive cancers like glioblastoma (GBM). With additional research operations in Ottawa, Canada, and a state-of-the-art research and manufacturing site in Rehovot, Israel, VBI Vaccines Inc. is committed to global health solutions.

VBI Vaccines Inc. continues to expand its research and development efforts, focusing on creating powerful tools for disease prevention and treatment. Management invites you to explore the potential of a customized and exclusive company showcase and product listing on our platform to further amplify your market presence. We encourage the team at VBI Vaccines Inc. to connect with us to explore this opportunity.